| 0 (0%) | 09-27 12:57 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 2.44 | 1-year : | 3.11 |
| Resists | First : | 2.09 | Second : | 2.67 |
| Pivot price | 1.36  |
|||
| Supports | First : | 1.16 | Second : | 0.97 |
| MAs | MA(5) : | 1.28 |
MA(20) : | 1.39 |
| MA(100) : | 1.54 |
MA(250) : | 1.72 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 7.1 |
D(3) : | 8.3 |
| RSI | RSI(14): 36.6 | |||
| 52-week | High : | 3.25 | Low : | 1.12 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ COCP ] has closed above bottom band by 22.6%. Bollinger Bands are 33.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.28 - 1.29 | 1.29 - 1.29 |
| Low: | 1.22 - 1.23 | 1.23 - 1.24 |
| Close: | 1.24 - 1.25 | 1.25 - 1.26 |
Wed, 17 Sep 2025
COCP: CDI-988 Showcased at Calicivirus Conference; Direct Offering Raises Up to $13 Million… - Yahoo Finance
Mon, 15 Sep 2025
Cocrystal Pharma, Inc. Announces Closing of Up To $13 - GlobeNewswire
Fri, 12 Sep 2025
COCP’s Norovirus Breakthrough: Opportunity or Risk? - timothysykes.com
Fri, 12 Sep 2025
Cocrystal Pharma Announces Stock Offering and Warrant Placement - MSN
Fri, 12 Sep 2025
Cocrystal Pharma (COCP) Announces $4.7M Direct Offering and Warr - GuruFocus
Fri, 12 Sep 2025
First-Ever Oral Drug for $60B Norovirus Market: Cocrystal's CDI-988 Shows Promise in Phase 1 Safety Study - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 10 (M) |
| Shares Float | 7 (M) |
| Held by Insiders | 28.3 (%) |
| Held by Institutions | 5.2 (%) |
| Shares Short | 41 (K) |
| Shares Short P.Month | 1 (K) |
| EPS | -1.25 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.51 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -52.9 % |
| Return on Equity (ttm) | -110.6 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | -0.76 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -1.24 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -13 (M) |
| Levered Free Cash Flow | -9 (M) |
| PE Ratio | -1.01 |
| PEG Ratio | 0 |
| Price to Book value | 2.4 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.96 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|